NovoCure Ltd. (NVCR)
NASDAQ · Healthcare
NovoCure Ltd. Cash on Hand 2013–2025
NovoCure Ltd. annual cash on hand history from 2014 to 2025. Cash on hand refers to the total amount of cash and cash equivalents held by a company.
- NovoCure Ltd. cash on hand as of December 31, 2025: 93.5M, a 42.88% decrease year-over-year.
- NovoCure Ltd. cash on hand for 2025 were 93.5M, a 42.88% decrease from 2024.
- NovoCure Ltd. cash on hand for 2024 were 163.8M, a 32.00% decrease from 2023.
- NovoCure Ltd. cash on hand for 2023 were 240.8M, a 108.82% increase from 2022.
- NovoCure Ltd. cash on hand for 2022 were 115.3M.
Cash on Hand
ANNUAL · $B
YEAR-OVER-YEAR GROWTH · %
| NovoCure Ltd. Annual Cash on Hand (Millions of US $) | |
|---|---|
| 2025 | $94 |
| 2024 | $164 |
| 2023 | $241 |
| 2022 | $115 |
| 2021 | $209 |
| 2020 | $235 |
| 2019 | $177 |
| 2018 | $141 |
| 2017 | $79 |
| 2016 | $100 |
| 2015 | $119 |
| 2014 | $58 |
NovoCure Ltd. Cash on Hand — FAQ
NovoCure Ltd. (NVCR) cash on hand over the last 13 years — annual and quarterly figures with year-over-year growth and charts.
Where can I see NVCR's cash on hand history?
The chart and table above show NovoCure Ltd.'s cash on hand by year and by quarter, including the growth rate.